Showing results (211-220 of 281) with videos related to

Sort By:
Pageof 29
Journal of Pediatric Hematology/Oncology|March 3, 1998
Thrombopoietin level in young patients is related to megakaryocyte frequency and platelet countM U Kuefer, W C Wang, D R Head, et al.
Investigational New Drugs|January 1, 1996
Topoisomerase I interactive drugs in children with cancerC F Stewart, W C Zamboni, W R Crom, et al.
Cancer|January 31, 2009
A phase 1/pilot study of radiofrequency ablation for the treatment of recurrent pediatric solid tumorsFredric A Hoffer, Najat C Daw, Xiaoping Xiong, et al.
The Journal of Biological Chemistry|November 28, 2018
Parkinson's disease and multiple system atrophy have distinct α-synuclein seed characteristicsTritia R Yamasaki, Brandon B Holmes, Jennifer L Furman, et al.
Medical and Pediatric Oncology|January 1, 1994
Failure of granulocyte-macrophage colony-stimulating factor to reduce febrile neutropenia in children with recurrent solid tumors treated with ifosfamide, carboplatin, and etoposide chemotherapyN M Marina, S J Shema, L C Bowman, et al.
Journal of Pediatric Surgery|March 26, 2002
Perianal rhabdomyosarcoma presenting as a perirectal abscess: A report of 11 casesD Ashley Hill, Louis P Dehner, Kenneth W Gow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2004
Phase I and pharmacokinetic study of topotecan administered orally once daily for 5 days for 2 consecutive weeks to pediatric patients with refractory solid tumorsNajat C Daw, Victor M Santana, Lisa C Iacono, et al.
Cancer|January 2, 2009
Phase 1 study of an oxaliplatin and etoposide regimen in pediatric patients with recurrent solid tumorsLisa M McGregor, Sheri L Spunt, Victor M Santana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
Pharmacokinetics of irinotecan and its metabolites SN-38 and APC in children with recurrent solid tumors after protracted low-dose irinotecanM K Ma, W C Zamboni, K M Radomski, et al.
Medical and Pediatric Oncology|January 1, 1994
Factors contributing to the prognostic significance of bone marrow involvement in childhood non-Hodgkin lymphomaJ T Sandlund, R Ribeiro, J S Lin, et al.
Pageof 29